Pulmonary Hypertension Research and Treatments
Pulmonary Hypertension Research and Treatments is a research topic within Pulmonary and Respiratory Medicine. Science Explorer counts 45k research works in it since 1950. 14.2% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the diagnosis, assessment, and treatment guidelines for pulmonary hypertension, with an emphasis on right heart assessment using echocardiography. It covers topics such as survival prediction, vascular remodeling, endothelial dysfunction, BMPR2 mutations, and hemodynamic classification.
- Pulmonary Hypertension
- Right Heart Assessment
- Echocardiography
- Treatment Guidelines
- Chronic Kidney Disease
- Survival Prediction
- Vascular Remodeling
- Endothelial Dysfunction
- BMPR2 Mutations
- Hemodynamic Classification
- Research works
- 45k fractional, since 1950
- In the world top 10%
- 6.3k per year above
- Top-10% rate
- 14.2% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +20% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Pulmonary Hypertension Research and Treatments research?
By volume, the United States and China publish the most (2.5k and 1.2k works in 2022–2025).
By volume, 2022–2025
- 1 United States 2.5k works
- 2 China 1.2k works
- 3 Japan 451 works
- 4 Germany 406 works
- 5 United Kingdom 397 works
- 6 Italy 342 works
- 7 France 279 works
- 8 India 252 works
- 9 Spain 238 works
- 10 Canada 200 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Pulmonary Hypertension Research and Treatments research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Pulmonary Hypertension Research and Treatments research, followed by Cleveland Clinic and University of Colorado Denver.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 65 works
- 2 Cleveland ClinicUnited States 40 works
- 3 University of Colorado DenverUnited States 38 works
- 4 Johns Hopkins UniversityUnited States 37 works
- 5 Mayo ClinicUnited States 35 works
- 6 University of ArizonaUnited States 35 works
- 7 University of Colorado Anschutz Medical CampusUnited States 35 works
- 8 University of California San DiegoUnited States 34 works
- 9 Stanford UniversityUnited States 33 works
- 10 Brigham and Women's HospitalUnited States 33 works
Who are the leading researchers in Pulmonary Hypertension Research and Treatments?
The most-cited researchers publishing on Pulmonary Hypertension Research and Treatments include Manoj M. Lalu and Valentı́n Fuster.
- 1 Manoj M. Lalu Canada 13k citations
- 2 Valentı́n Fuster United States 5.4k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Pulmonary Hypertension Research and Treatments research done?
The largest centres of Pulmonary Hypertension Research and Treatments research in 2022–2025 are Beijing (China), London (United Kingdom), Boston (United States) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in Le Kremlin-Bicêtre and Giessen.
Largest cities, 2022–2025
Where it is the local speciality
- Le Kremlin-BicêtreFR · 22.3 works74×
- GiessenDE · 70.2 works25×
Location quotient: how much more of its research is in Pulmonary Hypertension Research and Treatments than the world average.
Where is the best place to study Pulmonary Hypertension Research and Treatments?
Among universities, judged by research, Chinese Academy of Medical Sciences & Peking Union Medical College, University of Colorado Anschutz Medical Campus and Universities of Giessen and Marburg Lung Center score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina | 58.7 | 15.1% | 8.3× | 65 | +32.2% |
| 2 | University of Colorado Anschutz Medical CampusUnited States | 58.2 | 10.0% | 15.8× | 35 | +115.8% |
| 3 | Universities of Giessen and Marburg Lung CenterGermany | 57.9 | 22.3% | 234.4× | 14 | +19.0% |
| 4 | Medizinische Hochschule HannoverGermany | 57.5 | 18.9% | 10.8× | 19 | +64.2% |
| 5 | Medical University of GrazAustria | 57.1 | 24.3% | 13.9× | 14 | -10.1% |
| 6 | Semmelweis UniversityHungary | 53.9 | 12.8% | 9.6× | 15 | +123.4% |
| 7 | Medical University of ViennaAustria | 52.7 | 11.8% | 10.2× | 25 | -7.6% |
| 8 | Indiana University – Purdue University IndianapolisUnited States | 52.3 | 6.7% | 10.6× | 26 | +97.1% |
| 9 | Guangzhou Medical UniversityChina | 52.0 | 11.2% | 8.0× | 17 | +193.8% |
| 10 | Université Paris-SaclayFrance | 51.6 | 20.7% | 6.2× | 20 | — |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Pulmonary Hypertension Research and Treatments research growing?
Output in 2018–2022 was 20% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Pulmonary Hypertension Research and Treatments.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.